MUNJOVI
LIVE

Serial Number

90261241

Owner

MorphoSys AG

Attorney

Frances M. Jagla

Filing Date

Oct 17, 2020

Add to watchlist:

No watchlists yet
View on USPTO

MUNJOVI Trademark

Serial Number: 90261241 • Registration: 6625339

MUNJOVI is a trademark filed by MorphoSys AG on October 17, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MorphoSys AG (48 trademarks)

Lena-Christ-Strasse 48
82152 Martinsried/Planegg , DE

Entity Type: 03

Incyte Holdings Corporation (151 trademarks)

Wilmington, DE 19803

Entity Type: 03

Trademark Details

Filing Date

October 17, 2020

Registration Date

January 25, 2022

Published for Opposition

November 9, 2021

Goods & Services

Pharmaceuticals and pharmaceutical preparations for human use for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; biological preparations in the nature of antibodies for use in the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines; diagnostic preparations for medical purposes; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; sanitary preparations for medical use; medical diagnostic reagents; clinical medical reagents; Biological preparations for medical purposes for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis

Research and development in the pharmaceutical and biotechnology fields; research and development of medicines; scientific and technological services and research and design services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; biological research, clinical research in the field of antibodies and pharmaceuticals, and medical research; chemical and biochemical analysis services; laboratory research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer, sepsis, and restenosis; conducting clinical trials for others; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Research and development services in the field of antibodies

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 17, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 17, 2024 COAR
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 31, 2024 ASGN
REGISTERED-PRINCIPAL REGISTER
Jan 25, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 9, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 9, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 20, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 5, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 28, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 28, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 20, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 26, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 26, 2021 GNRT
NON-FINAL ACTION WRITTEN
Mar 26, 2021 CNRT
ASSIGNED TO EXAMINER
Mar 17, 2021 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Mar 9, 2021 AMPX
ASSIGNED TO LIE
Mar 1, 2021 ALIE
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 4, 2020 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Nov 27, 2020 PARI
NEW APPLICATION ENTERED
Oct 21, 2020 NWAP